Skip to content
value.today

Benson Hill Biosystems, Inc.

Total raised
$289 M
5 rounds on record
Latest round
$159 M
Jul 2020
First round on record
Aug 2015
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Benson Hill Biosystems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2020$159 MNo. 5$50 to $250 million

Benson Hill Biosystems, Inc.: Raise no. 5, Jul 2020

Investors in this round

21 investors had bought by the notice of Dec 18, 2020: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$159 M of $159 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$6,125,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris C Wilkins · Executive Officer
  • Matthew B Crisp · Executive Officer, Director
  • Michael B Wainscott · Executive Officer
  • Natalie B DiNicola · Executive Officer
  • Rebecca A Bortolotti · Executive Officer
  • Adrienne D Elsner · Director
  • Andy L Wheeler · Director
  • Daniel J Jacobi · Director
  • DeAnn L Brunts · Director
  • Mark G Cupta · Director
  • Michelle J Gloeckler · Director
  • Sanjeev J Krishnan · Director
  • Stephan G Dolezalek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Wedbush Securities Inc. (CRD 877) · Los Angeles, CaliforniaSold in all US states
  • William Blair & Company L.L.C. (CRD 1252) · Chicago, IllinoisSold in all US states
  • Lazard Freres & Co. LLC (CRD 2528) · New York, New YorkSold in all US states

Signed by Matthew B. Crisp, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 18, 2020. Read the notice at the SEC.

equitySEC
May 2019$33 MNo. 4$10 to $50 million

Benson Hill Biosystems, Inc.: Raise no. 4, May 2019

Investors in this round

17 investors had bought by the notice of Aug 2, 2019: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $33 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew B Crisp · Executive Officer, Director · President and Chief Executive Officer
  • Michael B Wainscott · Executive Officer · Chief Financial Officer
  • Nadine B Carozzi · Executive Officer · Secretary
  • Adrienne D Elsner · Director
  • Andy M Wheeler · Director
  • Daniel G Jacobi · Director
  • Daniel M Watkins · Director
  • Mark G Cupta · Director
  • Michelle J Gloeckler · Director
  • Sanjeev J Krishnan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael B. Wainscott, Cfo. Source: SEC Form D, newest notice filed Aug 2, 2019. Read the notice at the SEC.

equitySEC
Aug 2018$65 MNo. 3$50 to $250 million

Benson Hill Biosystems, Inc.: Raise no. 3, Aug 2018

Investors in this round

23 investors had bought by the notice of Nov 16, 2018: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$65 M of $65 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew B Crisp · Executive Officer, Director · President and Chief Executive Officer
  • Michael B Wainscott · Executive Officer · Chief Financial Officer
  • Nadine B Carozzi · Executive Officer · Secretary
  • Andy G Wheeler · Director
  • Dan G Jacobi · Director
  • Dan G Watkins · Director
  • Mark G Cupta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael B. Wainscott, Cfo. Source: SEC Form D, newest notice filed Nov 16, 2018. Read the notice at the SEC.

equitySEC
Mar 2017$25 MNo. 2$10 to $50 million

Benson Hill Biosystems, Inc.: Raise no. 2, Mar 2017

Investors in this round

16 investors had bought by the notice of May 10, 2017: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lee N Palles · Executive Officer
  • Matthew B Crisp · Executive Officer, Director
  • Nadine N Carozzi · Executive Officer
  • Dan B Jacobi · Director
  • Dan N Watkins · Director
  • David R Russell · Director
  • Mark R Cupta · Director
  • Scott R Horner · Director
  • Thomas B Klevorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew B Crisp, B. Source: SEC Form D and 2 amendments, newest notice filed May 10, 2017. Read the notice at the SEC.

equitySEC
Aug 2015$7 MNo. 1$2 to $10 million

Benson Hill Biosystems, Inc.: Raise no. 1, Aug 2015

Investors in this round

10 investors had bought by the notice of Aug 25, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $9 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lee C Palles · Executive Officer
  • Matthew B Crisp · Executive Officer, Director
  • Nadine C Carozzi · Executive Officer
  • Thomas P Brutnell · Executive Officer
  • Todd C Mockler · Executive Officer
  • Bruce A Jamerson · Director · Mr. Jamerson resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2
  • Daniel J Broderick · Director · Mr. Broderick resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-
  • Gregg J Bogosian · Director · Mr. Bogosian resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2
  • Walter P Siggelko · Director · Mr. Siggelko resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The above represents cash proceeds from the sale of Series A Preferred stock. In addition to the foregoing, $2,402,432 of existing Convertible Notes were pursuant to their terms automatically converted into shares of Series A Preferred stock.”

Signed by Matthew B Crisp, President. Source: SEC Form D, newest notice filed Aug 25, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Benson Hill Biosystems, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2020).

    SEC Form D · Dec 2020

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Dec 2020

That is all the official record says: Benson Hill Biosystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Benson Hill Biosystems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Benson Hill Biosystems, Inc.
NameRoleNamed in
Chris C WilkinsExecutive officerDec 2020
Matthew B CrispExecutive officerDec 2020
Michael B WainscottExecutive officerDec 2020
Natalie B DiNicolaExecutive officerDec 2020
Rebecca A BortolottiExecutive officerDec 2020
Nadine B CarozziSecretaryAug 2019
Lee N PallesExecutive officerMay 2017
Nadine N CarozziExecutive officerMay 2017
Lee C PallesExecutive officerAug 2015
Nadine C CarozziExecutive officerAug 2015
Thomas P BrutnellExecutive officerAug 2015
Todd C MocklerExecutive officerAug 2015
Adrienne D ElsnerDirectorDec 2020
Andy L WheelerDirectorDec 2020
Daniel J JacobiDirectorDec 2020
DeAnn L BruntsDirectorDec 2020
Mark G CuptaDirectorDec 2020
Matthew B CrispDirectorDec 2020
Michelle J GloecklerDirectorDec 2020
Sanjeev J KrishnanDirectorDec 2020
Stephan G DolezalekDirectorDec 2020
Andy M WheelerDirectorNov 2020
Daniel M WatkinsDirectorNov 2020
Daniel G JacobiDirectorAug 2019
Andy G WheelerDirectorNov 2018
Dan G JacobiDirectorNov 2018
Dan G WatkinsDirectorNov 2018
Dan B JacobiDirectorMay 2017
Dan N WatkinsDirectorMay 2017
David R RussellDirectorMay 2017
Mark R CuptaDirectorMay 2017
Scott R HornerDirectorMay 2017
Thomas B KlevornDirectorMay 2017
Bruce A JamersonMr. Jamerson resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2Aug 2015
Daniel J BroderickMr. Broderick resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-Aug 2015
Gregg J BogosianMr. Bogosian resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2Aug 2015
Walter P SiggelkoMr. Siggelko resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-2Aug 2015